Merck (MRK) recently revised its 2025 sales guidance to a range of $64.3 billion to $65.3 billion, acknowledging a slight foreign exchange impact, while also announcing lower year-over-year earnings ...

MARA Holdings (MARA) recently reported strong second-quarter results, with a significant turnaround in net income and impressive sales growth, contributing to its stock price increase of 24% over the ...